Rosina T. Lis

10.9k total citations
51 papers, 2.0k citations indexed

About

Rosina T. Lis is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Rosina T. Lis has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Rosina T. Lis's work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Cancer, Lipids, and Metabolism (14 papers). Rosina T. Lis is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Cancer, Lipids, and Metabolism (14 papers). Rosina T. Lis collaborates with scholars based in United States, Ireland and Sweden. Rosina T. Lis's co-authors include Massimo Loda, Lorelei A. Mucci, Philip W. Kantoff, Michelangelo Fiorentino, Edward L. Giovannucci, Michaela Bowden, Myles Brown, Kathryn L. Penney, Michelle S. Hirsch and Justine A. Barletta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Rosina T. Lis

49 papers receiving 2.0k citations

Peers

Countries citing papers authored by Rosina T. Lis

Since Specialization

Citations

This map shows the geographic impact of Rosina T. Lis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosina T. Lis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosina T. Lis more than expected).

Fields of papers citing papers by Rosina T. Lis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosina T. Lis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosina T. Lis. The network helps show where Rosina T. Lis may publish in the future.

Co-authorship network of co-authors of Rosina T. Lis

This figure shows the co-authorship network connecting the top 25 collaborators of Rosina T. Lis. A scholar is included among the top collaborators of Rosina T. Lis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosina T. Lis. Rosina T. Lis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer 2025 ·Molecular Cancer Research ·(unknown), Rosina T. Lis, Ying Huang, (unknown), (unknown), Emma H. Allott, Stephen P. Finn, Tamara L. Lotan, Michelangelo Fiorentino, Massimo Loda, Gwo‐Shu Mary Lee, Goutam Chakraborty, Philip W. Kantoff, Lorelei A. Mucci, Konrad H. Stopsack	0
2	Masked Image Modeling Meets Self-Distillation: A Transformer-Based Prostate Gland Segmentation Framework for Pathology Slides 2024 ·Cancers ·Haoyue Zhang, Sushant Patkar, Rosina T. Lis, Maria J. Merino, Peter Pinto, Peter L. Choyke, Barış Türkbey, Stephanie A. Harmon	1
3	Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions 2022 ·Molecular Cancer Research ·Konrad H. Stopsack, Xiaofeng A. Su, (unknown), Rebecca E. Graff, Ericka M. Ebot, Andreas Pettersson, Rosina T. Lis, Michelangelo Fiorentino, Massimo Loda, Kathryn L. Penney, Tamara L. Lotan, Lorelei A. Mucci	7
4	Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance 2021 ·Clinical Cancer Research ·Rana R. McKay, Lucia Kwak, Jett Crowdis, Jamie M. Sperger, Shuang G. Zhao, Wanling Xie, Lillian Werner, Rosina T. Lis, Zhenwei Zhang, Xiao X. Wei, Joshua M. Lang, Eliezer M. Van Allen, Rupal S. Bhatt, Evan Y. Yu, Peter S. Nelson, Glenn J. Bubley, Bruce Montgomery, Mary‐Ellen Taplin	21
5	Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum 2020 ·Molecular Cancer Research ·Kathryn L. Penney, Svitlana Tyekucheva, Jacob Rosenthal, (unknown), (unknown), (unknown), Giorgia Zadra, Giuseppe Nicolò Fanelli, (unknown), Francesca Giunchi, Mark M. Pomerantz, (unknown), (unknown), Rosina T. Lis, Adam S. Kibel, Michelangelo Fiorentino, Renato Umeton, Massimo Loda	28
6	Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone 2019 ·Journal of Clinical Oncology ·Rana R. McKay, Huihui Ye, Wanling Xie, Rosina T. Lis, Carla Calagua, Zhenwei Zhang, Quoc‐Dien Trinh, Steven L. Chang, Lauren C. Harshman, Ashley E. Ross, Kenneth J. Pienta, Daniel W. Lin, William J. Ellis, Bruce Montgomery, Peter Chang, Andrew A. Wagner, Glenn J. Bubley, Adam S. Kibel, Mary-Ellen Taplin	76
7	Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer–A Pilot Study 2019 ·Academic Radiology ·Fiona M. Fennessy, Andriy Fedorov, Márk Vangel, Robert V. Mulkern, Maria Tretiakova, Rosina T. Lis, Clare M. Tempany, Mary‐Ellen Taplin	11
8	Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations 2018 ·Cancer Research ·Adam G. Sowalsky, Huihui Ye, Manoj Bhasin, Eliezer M. Van Allen, Massimo Loda, Rosina T. Lis, Laleh Montaser‐Kouhsari, Carla Calagua, Fen Ma, Joshua W. Russo, Rachel Schaefer, Olga Voznesensky, Zhenwei Zhang, Glenn J. Bubley, Bruce Montgomery, Elahe A. Mostaghel, Peter S. Nelson, Mary‐Ellen Taplin, Steven P. Balk	38
9	Height, obesity, and the risk of TMPRSS2:ERG -defined prostate cancer 2018 ·DSpace@MIT (Massachusetts Institute of Technology) ·Rebecca E. Graff, Thomas U. Ahearn, Andreas Pettersson, Ericka M. Ebot, Travis Gerke, Kathryn L. Penney, Kathryn M. Wilson, Sarah C. Markt, Claire H. Pernar, Amparo G. Gonzalez‐Feliciano, Mingyang Song, Rosina T. Lis, Daniel R. Schmidt, Matthew G. Vander Heiden, Michelangelo Fiorentino, Edward L. Giovannucci, Massimo Loda, Lorelei A. Mucci	3
10	Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide 2017 ·Clinical Cancer Research ·Carla Calagua, Joshua W. Russo, Yue Sun, Rachel Schaefer, Rosina T. Lis, Zhenwei Zhang, Kathleen M. Mahoney, Glenn J. Bubley, Massimo Loda, Mary‐Ellen Taplin, Steven P. Balk, Huihui Ye	63
11	Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment 2017 ·Molecular Cancer Research ·Lisa Staunton, Claire Tonry, Rosina T. Lis, Virginia Espina, Lance A. Liotta, Rosanna Inzitari, Michaela Bowden, Aurélie Fabre, John O’Leary, Stephen P. Finn, Massimo Loda, Stephen R. Pennington	16
12	A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer 2016 ·Clinical Cancer Research ·Rana R. McKay, Lillian Werner, Elahe A. Mostaghel, Rosina T. Lis, Olga Voznesensky, Zhenwei Zhang, Brett T. Marck, Alvin M. Matsumoto, Liran Domachevsky, Katherine Zukotynski, Manoj Bhasin, Glenn J. Bubley, Bruce Montgomery, Philip W. Kantoff, Steven P. Balk, Mary‐Ellen Taplin	28
13	Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Kathryn L. Penney, Andreas Pettersson, Irene M. Shui, Rebecca E. Graff, Peter Kraft, Rosina T. Lis, Howard D. Sesso, Massimo Loda, Lorelei A. Mucci	18
14	Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6 2016 ·Cancer Research ·Atish D. Choudhury, Anna C. Schinzel, Maura B. Cotter, Rosina T. Lis, Katherine Labella, (unknown), Francesca Izzo, Isil Guney, Michaela Bowden, Yvonne Y. Li, Jinal Patel, Emily C. Hartman, Steven A. Carr, Monica Schenone, Jacob D. Jaffe, Philip W. Kantoff, Peter S. Hammerman, William C. Hahn	30
15	Prognostic Utility of a New mRNA Expression Signature of Gleason Score 2016 ·Clinical Cancer Research ·Jennifer A. Sinnott, (unknown), Svitlana Tyekucheva, Travis Gerke, Rosina T. Lis, Jennifer R. Rider, Michelangelo Fiorentino, Meir J. Stampfer, Lorelei A. Mucci, Massimo Loda, Kathryn L. Penney	49
16	Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression 2016 ·American Journal of Clinical Nutrition ·Rebecca E. Graff, Andreas Pettersson, Rosina T. Lis, Thomas U. Ahearn, Sarah C. Markt, Kathryn M. Wilson, Jennifer R. Rider, Michelangelo Fiorentino, Stephen P. Finn, Stacey A. Kenfield, Massimo Loda, Edward L. Giovannucci, Bernard Rosner, Lorelei A. Mucci	62
17	Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LCMSA technical report 2015 ·SHILAP Revista de lepidopterología ·Lisa Staunton, Claire Tonry, Rosina T. Lis, Stephen P. Finn, John O’Leary, Massimo Loda, Michaela Bowden, Stephen R. Pennington	11
18	Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma 2015 ·Clinical Genitourinary Cancer ·Stephanie A. Mullane, Lillian Werner, Elizabeth A. Guancial, Rosina T. Lis, Edward C. Stack, Massimo Loda, Philip W. Kantoff, Toni K. Choueiri, Jacob Rosenberg, Joaquim Bellmunt	31
19	Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues 2015 ·Journal of Molecular Diagnostics ·Svitlana Tyekucheva, Neil E. Martin, Edward C. Stack, Wei Wei, Vinod Vathipadiekal, Levi Waldron, Michelangelo Fiorentino, Rosina T. Lis, Meir J. Stampfer, Massimo Loda, Giovanni Parmigiani, Lorelei A. Mucci, Michael J. Birrer	23
20	The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis 2015 ·Nature Genetics ·Mark M. Pomerantz, Fugen Li, David Y. Takeda, Romina Lenci, Apurva Chonkar, Matthew Chabot, Paloma Cejas, Francisca Vázquez, Jennifer Cook, Ramesh A. Shivdasani, Michaela Bowden, Rosina T. Lis, William C. Hahn, Philip W. Kantoff, Myles Brown, Massimo Loda, Henry W. Long, Matthew L. Freedman	266

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact